BACKGROUND: Approximately 30% of older adults have disrupted gait. It is associated with increased risk of cognitive decline, disability, dementia, and death. Additionally, most older adults present with 1 or more neuropathologies at autopsy. Recently, there has been an effort to investigate the association between subclinical neuropathology and gait. SUMMARY: We reviewed studies that investigated the association between gait and neuropathologies. Although all pathologies reviewed were associated with gait, grey matter atrophy was most consistently linked with poorer gait performance. Studies investigating the association between white matter and gait focused primarily on total white matter. Future research using more parsed regional analysis will provide more insight into this relationship. Evidence from studies investigating neuronal activity and gait suggests that gait disruption is associated with both under- and overactivation. Additional research is needed to delineate these conflicting results. Lastly, early evidence suggests that both amyloid and tau aggregation negatively impact multiple gait parameters, but additional studies are warranted. Overall, there was substantial methodological heterogeneity and a paucity of longitudinal studies. Key Messages: Longitudinal studies mapping changes in different types of neuropathology as they relate to changes in multiple gait parameters are needed to better understand trajectories of pathology and gait.
BACKGROUND: Approximately 30% of older adults have disrupted gait. It is associated with increased risk of cognitive decline, disability, dementia, and death. Additionally, most older adults present with 1 or more neuropathologies at autopsy. Recently, there has been an effort to investigate the association between subclinical neuropathology and gait. SUMMARY: We reviewed studies that investigated the association between gait and neuropathologies. Although all pathologies reviewed were associated with gait, grey matter atrophy was most consistently linked with poorer gait performance. Studies investigating the association between white matter and gait focused primarily on total white matter. Future research using more parsed regional analysis will provide more insight into this relationship. Evidence from studies investigating neuronal activity and gait suggests that gait disruption is associated with both under- and overactivation. Additional research is needed to delineate these conflicting results. Lastly, early evidence suggests that both amyloid and tau aggregation negatively impact multiple gait parameters, but additional studies are warranted. Overall, there was substantial methodological heterogeneity and a paucity of longitudinal studies. Key Messages: Longitudinal studies mapping changes in different types of neuropathology as they relate to changes in multiple gait parameters are needed to better understand trajectories of pathology and gait.
Authors: Julie A Schneider; Jia-liang Li; Yan Li; Robert S Wilson; Jeffrey H Kordower; David A Bennett Journal: Ann Neurol Date: 2006-01 Impact factor: 10.422
Authors: J M Goldstein; L J Seidman; N J Horton; N Makris; D N Kennedy; V S Caviness; S V Faraone; M T Tsuang Journal: Cereb Cortex Date: 2001-06 Impact factor: 5.357
Authors: William R Markesbery; Frederick A Schmitt; Richard J Kryscio; Daron G Davis; Charles D Smith; David R Wekstein Journal: Arch Neurol Date: 2006-01
Authors: William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström Journal: Ann Neurol Date: 2004-03 Impact factor: 10.422
Authors: Joe Verghese; Aaron LeValley; Charles B Hall; Mindy J Katz; Anne F Ambrose; Richard B Lipton Journal: J Am Geriatr Soc Date: 2006-02 Impact factor: 5.562
Authors: Farwa Ali; Stacy R Loushin; Hugo Botha; Keith A Josephs; Jennifer L Whitwell; Kenton Kaufman Journal: J Neurol Sci Date: 2021-08-25 Impact factor: 4.553
Authors: Alexandra M V Wennberg; Clinton E Hagen; Mary M Machulda; John H Hollman; Rosebud O Roberts; David S Knopman; Ronald C Petersen; Michelle M Mielke Journal: Neurobiol Aging Date: 2018-02-19 Impact factor: 4.673
Authors: David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Brett M Frye; Suzanne Craft; Caitlin S Latimer; C Dirk Keene; Thomas J Montine; Thomas C Register; Miranda E Orr; Kylie Kavanagh; Shannon L Macauley; Carol A Shively Journal: Am J Primatol Date: 2021-04-05 Impact factor: 2.371